Boehringer Ingelheim’s Striverdi Respimat (olodaterol) Inhalation Spray for COPD Maintenance Gets FDA Approval
COPD, News
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim’s Striverdi® Respimat® (olodaterol) Inhalation Spray 5 µg to treat airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic ... Read more